- Home
- Publications
- Publication Search
- Publication Details
Title
Drugs acting on the renin–angiotensin system and SARS-CoV-2
Authors
Keywords
-
Journal
DRUG DISCOVERY TODAY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-01-22
DOI
10.1016/j.drudis.2021.01.010
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics
- (2020) David Gurwitz DRUG DEVELOPMENT RESEARCH
- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- (2020) Haibo Zhang et al. INTENSIVE CARE MEDICINE
- Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2
- (2020) Zhixin Liu et al. JOURNAL OF MEDICAL VIROLOGY
- Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2
- (2020) Renhong Yan et al. SCIENCE
- Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host–Virus Interaction, and Proposed Neurotropic Mechanisms
- (2020) Abdul Mannan Baig et al. ACS Chemical Neuroscience
- Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2
- (2020) Guoshuai Cai et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19
- (2020) Reinhold Kreutz et al. CARDIOVASCULAR RESEARCH
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study
- (2020) Francisco J de Abajo et al. LANCET
- Interaction between RAAS inhibitors and ACE2 in the context of COVID-19
- (2020) Jean-Jacques Mourad et al. Nature Reviews Cardiology
- Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
- (2020) Giuseppe Mancia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
- (2020) Harmony R. Reynolds et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
- (2020) Mandeep R. Mehra et al. NEW ENGLAND JOURNAL OF MEDICINE
- The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2
- (2020) Francesco Ferrara et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Angiotensin‐converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID‐19 infection in a multi‐site UK acute hospital trust
- (2020) Daniel M. Bean et al. EUROPEAN JOURNAL OF HEART FAILURE
- The renin angiotensin aldosterone system and its therapeutic targets
- (2019) Katrina M. Mirabito Colafella et al. EXPERIMENTAL EYE RESEARCH
- Targeting the renin–angiotensin system as novel therapeutic strategy for pulmonary diseases
- (2018) Wan Shun Daniel Tan et al. CURRENT OPINION IN PHARMACOLOGY
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
- (2018) Paul K. Whelton et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2018 ESC/ESH Guidelines for the management of arterial hypertension
- (2018) Bryan Williams et al. JOURNAL OF HYPERTENSION
- Efficiency and specificity of RAAS inhibitors in cardiovascular diseases: how to achieve better end-organ protection?
- (2017) Ali Nehme et al. HYPERTENSION RESEARCH
- Angiotensin-(1-7) Inhibits Thrombin-Induced Endothelial Phenotypic Changes and Reactive Oxygen Species Production via NADPH Oxidase 5 Downregulation
- (2017) Wan-Yu Pai et al. Frontiers in Physiology
- Role of the ACE2/Angiotensin 1–7 Axis of the Renin–Angiotensin System in Heart Failure
- (2016) Vaibhav B. Patel et al. CIRCULATION RESEARCH
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN HEART JOURNAL
- Angiotensin-(1-7) attenuates airway remodelling and hyperresponsiveness in a model of chronic allergic lung inflammation
- (2015) G S Magalhães et al. BRITISH JOURNAL OF PHARMACOLOGY
- Angiotensin-Converting Enzyme 2/Angiotensin-(1-7)/Mas Axis Protects against Lung Fibrosis by Inhibiting the MAPK/NF-κB Pathway
- (2013) Ying Meng et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2-/- mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation
- (2013) C. Fang et al. BLOOD
- ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis
- (2013) AC Simões e Silva et al. BRITISH JOURNAL OF PHARMACOLOGY
- Multiple Functions of Angiotensin-Converting Enzyme 2 and Its Relevance in Cardiovascular Diseases
- (2013) Keiji Kuba et al. CIRCULATION JOURNAL
- An evolving story of angiotensin-II-forming pathways in rodents and humans
- (2013) Carlos Maria Ferrario et al. CLINICAL SCIENCE
- Angiotensin-(1-7) attenuates lung fibrosis by way of Mas receptor in acute lung injury
- (2013) Qiuhua Chen et al. JOURNAL OF SURGICAL RESEARCH
- Angiotensin-(1-7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1/2- and NF-κB-dependent pathways
- (2012) Ahmed Z El-Hashim et al. BRITISH JOURNAL OF PHARMACOLOGY
- Macrophage Polarization by Angiotensin II-Type 1 Receptor Aggravates Renal Injury-Acceleration of Atherosclerosis
- (2011) Suguru Yamamoto et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- An orally active formulation of angiotensin-(1-7) produces an antithrombotic effect
- (2011) Rodrigo Araujo Fraga-Silva et al. Clinics
- Tissue Renin-Angiotensin-Aldosterone Systems: Targets for Pharmacological Therapy
- (2010) Michael Bader Annual Review of Pharmacology and Toxicology
- Angiotensin-(1–9) regulates cardiac hypertrophy in vivo and in vitro
- (2010) Maria Paz Ocaranza et al. JOURNAL OF HYPERTENSION
- Angiotensin1-9 antagonises pro-hypertrophic signalling in cardiomyocytes via the angiotensin type 2 receptor
- (2010) M. Flores-Muñoz et al. JOURNAL OF PHYSIOLOGY-LONDON
- Telmisartan attenuates aortic hypertrophy in hypertensive rats by the modulation of ACE2 and profilin-1 expression
- (2010) Jiu-Chang Zhong et al. REGULATORY PEPTIDES
- Unknown
- (2008) Rodrigo Fraga-Silva et al. MOLECULAR MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now